Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?
Marcio SouzaChief Executive Officer2023-06-2710,000$1.06
Marcio SouzaChief Executive Officer2023-05-1211,687$0.88
Timothy Edwin KellyChief Financial Officer2023-05-1211,683$0.88
Alex NemiroffGeneral Counsel and Secretary2023-05-1211,686$0.88
Timothy Edwin KellyChief Financial Officer2023-03-248,000$0.88
Dean J. MitchellDirector2023-03-2450,000$0.84
Timothy Edwin KellyChief Financial Officer2023-03-248,000$0.88
Marcio SouzaChief Executive Officer2023-03-2335,001$0.86
Marcio SouzaChief Executive Officer2023-03-2335,000$0.86
Nicole SweenyChief Commercial Officer2023-02-121,456$3.94

1 of 2

PRAX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?
Point72 Asset Management LP8.21%10,550,000$18.04MInstitution
Verition Fund Management LLC8.16%10,487,828$17.93MInstitution
Cormorant Asset Management LP7.39%9,500,000$16.25MInstitution
Pfm Health Sciences LP6.92%8,891,762$15.20MInstitution
Sphera Funds Management Ltd6.82%8,764,334$14.99MInstitution
Adage Capital Partners GP LLC6.17%7,930,638$13.56MInstitution
Vr Adviser LLC4.13%5,304,410$9.07MInstitution
Kingdon Capital Management LLC4.05%5,200,000$8.89MInstitution
Velan Capital Investment Management LP4.03%5,185,000$8.87MInstitution
Bsof Parallel Master Fund LP3.81%4,894,109$8.37MInsider

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX90.48%9.52%Net Buying
AEON3.57%62.56%Net SellingNet Selling
AKBA26.68%9.00%Net Selling
STRO78.53%21.47%Net SellingNet Selling
GBIO65.74%34.26%Net SellingNet Selling

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 91.08% institutional shareholders, 9.58% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 3.81% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $8.17M.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.